What is the recommended management protocol for an acute myocardial infarction?

Protocol for Active MI

For acute myocardial infarction, immediately administer aspirin and obtain a 12-lead ECG within 10 minutes, then pursue primary PCI as the definitive reperfusion strategy—or fibrinolytic therapy if PCI cannot be performed within 120 minutes—while simultaneously initiating dual antiplatelet therapy and anticoagulation. 1

Immediate Actions (First 10 Minutes)

Diagnosis & Monitoring

• Obtain 12-lead ECG within 10 minutes of first medical contact to distinguish STEMI from NSTE-ACS 1
• Initiate continuous ECG monitoring with defibrillator capacity immediately 1
• Avoid routine oxygen unless SaO₂ <90% 1

Initial Pharmacotherapy

• Aspirin 160-325 mg (oral or IV if unable to swallow) immediately unless contraindicated 1
• Morphine 2-4 mg IV for pain relief if needed 2
• Nitroglycerin sublingual, then 10-20 mcg/min IV if systolic BP >100 mmHg 2

Reperfusion Strategy (Time-Critical)

For STEMI (<12 hours from symptom onset):

Primary PCI is the preferred reperfusion method 1

• Transfer directly to catheterization laboratory, bypassing emergency department 1
• Target door-to-balloon time: <120 minutes 3
• Reduces mortality from 9% to 7% compared to no reperfusion 3

If PCI cannot be performed within 120 minutes:

• Initiate fibrinolytic therapy immediately, preferably pre-hospital 1
• Use fibrin-specific agents: tenecteplase, alteplase, or reteplase 1
  • Full dose for patients <75 years
  • Half dose for patients ≥75 years 3
• Transfer to PCI-capable center immediately after fibrinolysis 1
• Perform angiography and PCI of infarct-related artery 2-24 hours after successful fibrinolysis 1

For NSTE-ACS:

• High-risk patients: invasive angiography within 24-48 hours (reduces mortality from 6.5% to 4.9%) 3
• Emergency angiography if heart failure, shock, or hemodynamic instability 1

Antithrombotic Therapy

Antiplatelet Therapy (Dual Antiplatelet Therapy - DAPT)

For Primary PCI:

• Potent P2Y₁₂ inhibitor (prasugrel or ticagrelor preferred over clopidogrel) before or at time of PCI 1
• Continue DAPT for 12 months unless excessive bleeding risk 1
• Add PPI if high gastrointestinal bleeding risk 1

For Fibrinolytic Strategy:

• Clopidogrel in addition to aspirin 1
• Aspirin oral or IV 1

Anticoagulation

For Primary PCI:

• Use UFH or enoxaparin (fondaparinux is NOT recommended for primary PCI) 1

For Fibrinolytic Therapy:

• Enoxaparin IV followed by subcutaneous (preferred over UFH) 1
• Alternative: UFH as weight-adjusted IV bolus followed by infusion 1
• Continue until revascularization or up to 8 days of hospital stay 1

Rescue & Contingency Interventions

Rescue PCI is indicated immediately if:

• Fibrinolysis fails (<50% ST-segment resolution at 60-90 minutes) 1
• Hemodynamic or electrical instability develops 1
• Worsening ischemia occurs 1

For Cardiogenic Shock:

• Culprit-lesion-only initial PCI strategy 4
• Emergency angiography and PCI 1
• Consider intra-aortic balloon pump for refractory pulmonary congestion 2
• Inotropic support: dobutamine 2-20 mcg/kg/min or dopamine 5-15 mcg/kg/min if SBP 70-100 mmHg 2

In-Hospital Management

Diagnostic Assessment

• Routine echocardiography during hospital stay to assess LV/RV function, detect mechanical complications, and exclude LV thrombus 1
• High-sensitivity troponin for NSTEMI diagnosis 3

Medical Therapy Initiation

Beta-blockers:

• Oral therapy for patients with heart failure and/or LVEF <40% 1
• Avoid IV beta-blockers if hypotension, acute heart failure, AV block, or severe bradycardia 1

ACE Inhibitors:

• Start within first 24 hours if heart failure, LV systolic dysfunction, diabetes, or anterior infarct 1
• Alternative: ARB (valsartan) if ACE inhibitor intolerant 1

Statins:

• High-intensity statin therapy started as early as possible 1
• Target LDL-C <1.8 mmol/L (70 mg/dL) or ≥50% reduction if baseline 1.8-3.5 mmol/L 1
• Add ezetimibe early when needed 4

Mineralocorticoid Receptor Antagonists:

• For patients with EF <40% and heart failure or diabetes, already receiving ACE inhibitor and beta-blocker 1

Common Pitfalls to Avoid

1. Do not delay reperfusion for complete laboratory workup—ECG diagnosis is sufficient to proceed 1
2. Do not use fondaparinux for primary PCI (Class III recommendation) 1
3. Do not perform routine PCI of occluded infarct-related artery >48 hours after STEMI onset in asymptomatic patients 1
4. Do not give IV beta-blockers to patients with signs of heart failure or hypotension 1
5. Do not use pre-hospital cooling with rapid infusion of cold IV fluid after cardiac arrest 1

Post-Discharge Considerations

• Continue low-dose aspirin 75-100 mg daily indefinitely 1
• Maintain DAPT for 12 months 1
• Cardiac rehabilitation program participation 1
• Smoking cessation with pharmacotherapy support 1